alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Exhibit 32.1
                           Small Cap Strategies, Inc.
              Form 10-K for the fiscal year ended December 31, 2006
    Certification of the Chief Executive Officer and Chief Financial Officer
                 Pursuant to 18 U.S.C. SECTION 1350, as Adopted
            Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

I, Bryce Knight, certify that:

     1.   I am the chief executive  officer and chief financial officer of Small
          Cap Strategies, Inc.

     2.   Attached to this  certification is Form 10-K for the fiscal year ended
          December 31, 2006, a periodic report (the "periodic  report") filed by
          the issuer with the Securities Exchange Commission pursuant to Section
          13(a)  or  15(d)  of the  Securities  and  Exchange  Act of 1934  (the
          "Exchange Act"), which contains financial statements.

     3.   I hereby  certify,  pursuant  to 18 U.S.C.  Section  1350,  as adopted
          pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

          o    The periodic  report  containing the financial  statements  fully
               complies with the  requirements  of Section 13(a) or 15(d) of the
               Exchange Act, and

          o    The  information in the periodic report fairly  presents,  in all
               material  respects,   the  financial  condition  and  results  of
               operations of the issuer for the periods presented.

April 6, 2007                             /s/ Bryce Knight
                                          Bryce Knight
                                          President, Chief Executive Officer and
                                          Chief Financial Officer


A signed  original of this  written  statement  required by Section 906 has been
provided to the Company and will be retained by Small Cap  Strategies,  Inc. and
furnished to the Securities and Exchange Commission or its staff upon request.

This  certification will not be deemed "filed" for purposes of Section 18 of the
Securities  Exchange Act of 1934, or otherwise  subject to the liability of that
section.  This  certification will not be deemed to be incorporated by reference
into any filing under the Securities Act of 1933 or the Securities  Exchange Act
of 1934 even if the document  with which it is submitted to the  Securities  and
Exchange Commission is so incorporated by reference.



                                 Page 94 of 94
**EXHIBIT 32.1****CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THESARBANES-OXLEY ACT OF 2002**     In connection with the annual report of Natural Health Trends Corp. (the “Company”) on Form10-K for the period ended December 31, 2005, as filed with the Securities and Exchange Commissionon the date hereof (the “Report”), I, Chris T. Sharng, Interim Principal Executive Officer of theCompany, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to Section 906 of theSarbanes-Oxley Act of 2002, that to the best of my knowledge:1. The Report fully complies with the requirements of Section 13(a) or 15(d) of theSecurities Exchange Act of 1934; and2. The information contained in the Report fairly presents, in all material respects, thefinancial condition and results of operations of the Company.   Date: May 8, 2006 /s/ Chris T. Sharng     Chris T. Sharng  Interim Principal Executive Officer
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Commerce

          - [I.D. 022701A]

      ( print page 13043)    
The Department of Commerce has submitted to the Office of  Management and Budget (OMB) for clearance the following proposal for  collection of information under the provisions of the Paperwork  Reduction Act (44 U.S.C. Chapter 35).

*Agency*: National Oceanic and Atmospheric Administration (NOAA).                

*Title*: Dr. Nancy Foster Scholarship Program.                

*Form Number(s)*: None.                

*OMB Approval Number*: None.                

*Type of Request*: Emergency.                

*Burden Hours*: 725.                

*Number of Respondents*: 400.                

*Average Hours Per Response*: 5 hours for an application, 45 minutes for a recommendation.                

*Needs and Uses*:  The Dr. Nancy Foster Scholarship Program recognizes outstanding scholarship by providing financial support to graduate students pursuing masters and doctoral degrees in the areas of marine biology, oceanography, and maritime archaeology.  Applicants must submit documentation that NOAA uses to select candidates, including three letters of recommendation.                

*Affected Public*: Individuals or households.                

*Frequency*: On occasion.                

*Respondent's Obligation*: Require to obtain or retain a benefit.                

*OMB Desk Officer*: David Rostker, (202) 395-3897.                

Copies of the above information collection proposal can be obtained by calling or writing Madeleine Clayton, Departmental Forms Clearance Officer,  (202) 482-3129, Department of Commerce, Room 6086, 14th and Constitution Avenue, NW, Washington, DC 20230 (or via the Internet at MClayton@doc.gov).

Written comments and recommendations for the proposed information collection should be sent within 30 days of publication of this notice to David Rostker, OMB Desk Officer, Room 10202, New Executive Office Building, Washington, DC 20503.

Dated: February 23, 2001.

Gwellnar Banks,

Management Analyst, Office of the Chief Information Officer.

[FR Doc. 01-5132 Filed 3-1-01; 8:45 am]

BILLING CODE 3510-JT-S
USDA Food Safety and Inspection Service 

-= US. Dm\RT'-E<T OF AGROl.Tl.RE 

• 

• 

\-.fJ.\f....r:,. 

1f0f('C"n1C'lll 

vcstigntion 

1alysiS 

mrer 

Insert Photo

If Desired

1

2

7/15/2022

Category Specific Hazards and Issues EIAO Training

1

Category Specific Issues

• There are category specific food safety issues that must be addressed in

the FSA

• Examples

• Lm controls in PLE RTE products

• E. coli 0157:H7 in raw beef products

• SRMs in beef slaughter

• NRTE comminuted poultry

• Ingredients of Public Health Concern

2

FSA Tool Questions Related to Ingredients

of Public Health Concern

• EIAO will gatherinfo about how establishments address the presence

and control of allergens

• Compliance Guidelines: Allergens and Ingredients of Public Health

Concern: Identification, Prevention and Control, and Declaration through

Labeling

• EIAOs are to review this prior to FSAs

3

3

1
 

 

 

 

 

 

 

 

 

 

 

 

 

 

• 

• 

• 

4

5

7/15/2022

Raw Processes

• The EIAO will observe and assess sanitary dressing and process control

• Discuss with IIC and FLS

• Document information gathered

4

Raw Meat Processes

• Process control is crucial here as well

• Use these tools to verify:

• E. coli 0157:H7 is properly addressed in raw beef

• SRMs are properly addressed in raw beef

• HACCP systems are effective

5

Raw Meat Processes

• For establishments producing non-intact raw beef products:

• Use information in Directive 10010.1 Rev 4 and the FRN - 64 FR 2803

1/19/1999

• If mechanically tenderized, are validated cooking instructions used?

• Answer questions in the tool

6

6

2
 

 

 

 

 

 

 

weJ6oJd 

ms ese1,pJnd 

'I- --

• 

• 

7

8

7/15/2022

Processes Meat Raw

programs specification purchase use of the assess Critically •

analysis hazard the decision in the for support is if there Determine •

7

Processes Meat Raw

following the how consider and operations establishment Observe •

effectiveness: system’s HACCP products raw the to relate

practices Sanitary •

interventions Antimicrobial •

effectiveness Testing •

training and practices Employee •

PR programs, GMPs •

practices Labeling •

8

3
UNPUBLISHED

UNITED STATES COURT OF APPEALS

FOR THE FOURTH CIRCUIT

No. 96-6489

STANTON MAURICE HOFFMAN,

Plaintiff - Appellant,

versus

LEWIS DAVIS, Correctional Lieutenant; FRANKLIN

FREEMAN, Secretary of Corrections,

Defendants - Appellees.

No. 96-6709

STANTON MAURICE HOFFMAN,

Plaintiff - Appellant,

versus

LEWIS DAVIS, Correctional Lieutenant; FRANKLIN

FREEMAN, Secretary of Corrections,

Defendants - Appellees.

Appeals from the United States District Court for the Western District of North Carolina, at Asheville. Richard L. Voorhees, Chief

District Judge; Graham C. Mullen, Lacy H. Thornburg, District

Judges. (CA-94-71-MU)
2

Submitted: July 25, 1996 Decided: August 7, 1996

Before LUTTIG and MOTZ, Circuit Judges, and PHILLIPS, Senior

Circuit Judge.

No. 96-6489 affirmed in part and dismissed in part and No. 96-6709

dismissed by unpublished per curiam opinion.

Stanton Maurice Hoffman, Appellant Pro Se. Michael F. Easley,

David L. Woodard, NORTH CAROLINA DEPARTMENT OF JUSTICE, Raleigh,

North Carolina, for Appellees.

Unpublished opinions are not binding precedent in this circuit.

See Local Rule 36(c).
3

PER CURIAM:

In No. 96-6709, Appellant appeals the district court's order

dismissing several claims, but denying in part the Defendants'

motion for summary judgment. Similarly, in No. 96-6489, Appellant

appeals the district court's orders denying several mundane pretrial motions and declining to issue a preliminary injunction. This

court may exercise jurisdiction only over final orders, 28 U.S.C.

§ 1291 (1988), and certain interlocutory and collateral orders, 28

U.S.C. § 1292 (1988); Fed. R. Civ. P. 54(b); Cohen v. Beneficial

Indus. Loan Corp., 337 U.S. 541 (1949). The order appealed in

No. 96-6709 is neither a final order nor an appealable interlocutory or collateral order. We therefore dismiss that appeal.

In No. 96-6489, to the extent that Appellant seeks review of

the denial of his motion for a preliminary injunction, this court

has jurisdiction over that portion of the appeal. 28 U.S.C.

§ 1292(a)(1) (1988). We note, however, that Appellant failed to

make the necessary showing of a likelihood of success on the merits

to warrant a preliminary injunction. See Blackwelder Furniture Co.

v. Seilig Mfg. Co., 550 F.2d 189, 193 (4th Cir. 1977). Accordingly,

the district court did not err in denying the motion and is hereby

affirmed. As the remainder of this appeal seeks review of mundane

pretrial motions, it is also interlocutory and is therefore

dismissed.

We dismiss No. 96-6709 as interlocutory. In No. 96-6489, we

affirm the district court's denial of a preliminary injunction and

dismiss the remainder of the appeal. We dispense with oral argument
4

because the facts and legal contentions are adequately presented in

the materials before the court and argument would not aid the

decisional process.

No. 96-6489 - AFFIRMED IN PART,

DISMISSED IN PART

No. 96-6709 - DISMISSED
United States Department of Agriculture

Food Safety and 

Inspection Service

Office of Field 

Operations

Denver District Office

1 Denver Federal

Center, Bldg. 45

P.O. Box 25387

Denver, CO 80225

Voice (303)236-9800

Fax (303)236-9794

Swift Beef Company 

Establishment M969G 

555 S. Stuhr Rd.

Grand Island, Nebraska 

phillip.buck2@jbssa.com

308-392-9732

Attention: Mr. Phillip Buck, Plant Manager

September 17, 2023

SENT VIA ELECTRONIC MAIL

NOTICE OF SUSPENSION HELD IN ABEYANCE (NOSHA)

On September 17, 2023, the Food Safety Inspection Service (FSIS) issued your establishment, 

Swift Beef Company, M969G, a Notice of Suspension (NOS). The decision to issue the NOS 

was made in accordance with Title 9 of the Code of Federal Regulations (CFR), Rules of 

Practice 500.3(b), based on the determination that your establishment did not handle or 

slaughter animals humanely. The evidence demonstrates failure to comply with the Federal 

Meat Inspection Act (FMIA) (21 U.S.C. 603), the Humane Methods of Slaughter Act (HMSA) 

(7 U.S.C. 1901 et seq.), and the regulatory requirements (9 CFR Part 313). 

Correspondence was received via email from your firm on September 17, 2023. Your 

responses included information on training, monitoring, and maintenance examinations and 

movement of equipment. After reviewing the responses and based upon your proposed 

corrective actions FSIS will hold the suspension of inspectors at your establishment in 

abeyance.

The suspension will remain in abeyance pending verification by FSIS inspection personnel. 

During this abeyance period, FSIS will continue to verify, assess, and evaluate the 

effectiveness of your proffered corrective actions to ensure that these are adequately 

implemented, and confirm that livestock are properly handled and slaughtered humanely. 

FSIS will design a verification plan to confirm that your establishment is implementing the 

corrective actions you provided in your response to the NOS. The verification plan identifies 

your corrective action plan, the relevant regulations and the frequency FSIS inspection 

personnel will verify the implementation and effectiveness of your proffered actions. 

FSIS will provide you a copy of the verification plan. Please be advised that only FSIS can 

amend the verification plan. If your establishment wishes to modify your proposed 

corrective actions during the abeyance period, please submit these changes, in writing, to 

FSIS for approval prior to making any changes in your actions. 

FSIS reminds you that as an operator of a federally inspected facility, you are expected to 

comply with the Federal Meat Inspection Act (FMIA), the Humane Methods of Slaughter 

Act (HMSA) and the regulations in 9 CFR 313 to ensure livestock at your establishment are
Exhibit 23



               CONSENT OF INDEPENDENT CERTIFIED PUBLIC ACCOUNTANTS









The Board of Directors and Stockholders
ALLIED Life Financial Corporation


We consent to  incorporation  by reference in the  Registration  Statement  Nos.
33-71906, 33-71960, 33-71962, 33-76874 and 33-83274 on Form S-8, and 33-92206 on
Form S-3 of ALLIED Life Financial  Corporation of our reports dated February 12,
1998  relating  to the  consolidated  balance  sheets of ALLIED  Life  Financial
Corporation  and  subsidiaries as of December 31, 1997 and 1996, and the related
consolidated  statements  of earnings,  stockholders'  equity and cash flows and
related  schedules for each of the years in the three-year period ended December
31, 1997, which appears in the December 31, 1997,  annual report on Form 10-K of
ALLIED Life Financial Corporation.




                                                    /s/KPMG Peat Marwick LLP
                                                       KPMG Peat Marwick LLP

Des Moines, Iowa
March 20, 1998


                                       96
EXHIBIT
32.1
  Certification
 Pursuant
to Section 906 of the Sarbanes-Oxley Act of 2002
 (Subsections
(a) and (b) of Section 1350, Chapter 63 of Title 18, United States
Code)
  In
connection with the Quarterly Report on Form 10-Q of Pressure BioSciences, Inc.,
a Massachusetts corporation (the “Company”) for the period ended March 31, 2009
as filed with the Securities and Exchange Commission on the date hereof (the
“Report”), I, Richard T. Schumacher, President and Chief Executive Officer of
the Company, do hereby certify, pursuant to Section 906 of the Sarbanes-Oxley
Act of 2002 (subsections (a) and (b) of Section 1350, Chapter 63 of Title 18,
United States Code) that:
 
 (1)
  The Report of the Company fully complies with the requirements of Section
13(a) or 15(d) of the Securities Exchange Act of 1934; and
 
 (2)
  The information contained in the Report fairly presents, in all material
respects, the financial condition and results of operations of the
Company.
  Date: May
      15, 2009
                By:
                /s/   Richard T.
      SchumacherRichard
      T. Schumacher
                  President
      & Chief Executive Officer
                  (Principal
      Executive Officer)
  A signed
original of this written statement required by Section 906 has been provided to
Pressure BioSciences, Inc. and will be retained by Pressure BioSciences, Inc.
and furnished to the Securities and Exchange Commission or its staff upon
request.
2009-0141.

#### State ex rel. Galligan v. Indus. Comm.

Franklin App. No. 08AP-36, 2008-Ohio-6426. Reported at 124 Ohio St.3d 233, 2010-Ohio-3, 921 N.E.2d 231. On motion for reconsideration. Motion denied.
EXHIBIT 99(b)

                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

         In connection with the Quarterly Report of Superconductive Components,
Inc. (the "Company"), on Form 10-QSB for the period ending September 30, 2002,
as filed with the Securities and Exchange Commission on the date hereof (the
"Report"), I, Gerald S. Blaskie, Chief Financial Officer of the Company,
certify, pursuant to 18 U.S.C. ss. 1350, as adopted pursuant to ss. 906 of the
Sarbanes-Oxley Act of 2002, that:

                  (1) The Report fully complies with the requirements of section
13(a) or 15(d) of the Securities Exchange Act of 1934; and

                  (2) The information contained in the Report fairly presents,
in all material respects, the financial condition and results of operations of
the Company.

                                                     /s/ Gerald S. Blaskie
                                                     ---------------------------
                                                     Gerald S. Blaskie
                                                     Chief Financial Officer
                                                     November 8, 2002
[Federal Register Volume 66, Number 42 (Friday, March 2, 2001)]
[Notices]
[Page 13043]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 01-5132]



[[Page 13043]]

=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF COMMERCE

[I.D. 022701A]


Submission for OMB Review; Comment Request

    The Department of Commerce has submitted to the Office of 
Management and Budget (OMB) for clearance the following proposal for 
collection of information under the provisions of the Paperwork 
Reduction Act (44 U.S.C. Chapter 35).
    Agency: National Oceanic and Atmospheric Administration (NOAA).
    Title: Dr. Nancy Foster Scholarship Program.
    Form Number(s): None.
    OMB Approval Number: None.
    Type of Request: Emergency.
    Burden Hours: 725.
    Number of Respondents: 400.
    Average Hours Per Response: 5 hours for an application, 45 minutes 
for a recommendation.
    Needs and Uses: The Dr. Nancy Foster Scholarship Program recognizes 
outstanding scholarship by providing financial support to graduate 
students pursuing masters and doctoral degrees in the areas of marine 
biology, oceanography, and maritime archaeology. Applicants must submit 
documentation that NOAA uses to select candidates, including three 
letters of recommendation.
    Affected Public: Individuals or households.
    Frequency: On occasion.
    Respondent's Obligation: Require to obtain or retain a benefit.
    OMB Desk Officer: David Rostker, (202) 395-3897.
    Copies of the above information collection proposal can be obtained 
by calling or writing Madeleine Clayton, Departmental Forms Clearance 
Officer, (202) 482-3129, Department of Commerce, Room 6086, 14th and 
Constitution Avenue, NW, Washington, DC 20230 (or via the Internet at 
<a href="/cdn-cgi/l/email-protection#f7bab49b968e839899b7939894d9909881"><span class="__cf_email__" data-cfemail="aee3edc2cfd7dac1c0eecac1cd80c9c1d8">[email protected]</span></a>).
    Written comments and recommendations for the proposed information 
collection should be sent within 30 days of publication of this notice 
to David Rostker, OMB Desk Officer, Room 10202, New Executive Office 
Building, Washington, DC 20503.

    Dated: February 23, 2001.
Gwellnar Banks,
Management Analyst, Office of the Chief Information Officer.
[FR Doc. 01-5132 Filed 3-1-01; 8:45 am]
BILLING CODE 3510-JT-S


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
**Exhibit32.1**

 

# **Certification**

# **Pursuant to Section 906 of the Sarbanes-Oxley Act of2002**

**(Subsections (a) and (b) of Section1350, Chapter 63 of Title 18, United States Code)**

 

In connection with theQuarterly Report on Form 10-Q of Boston Biomedica, Inc., a Massachusettscorporation (the “Company”) for the period ended June 30, 2004 as filed withthe Securities and Exchange Commission on the date hereof (the  “Report”), I, Richard T. Schumacher, Chief Executive Officer of Boston Biomedica,Inc., a Massachusetts corporation (the “Company”), do hereby certify, pursuantto Section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) ofSection 1350, Chapter 63 of Title 18, United States Code) that:

 

(1)           The Report of the Company fully complies with the requirementsof Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

(2)           The information contained in the Report fairly presents,in all material respects, the financial condition and results of operations ofthe Company.

 

 
| Dated: August 16, 2004 | */s/  Richard T. Schumacher*   |   |
|------------------------|--------------------------------|--------|
|                   | Richard T. Schumacher          |
|                   | Chief Executive Officer        |
|                   | (Principal Executive  Officer) |

 

 

A signed original of this written statementrequired by Section 906 has been provided to Boston Biomedica, Inc. and will beretained by Boston Biomedica, Inc. and furnished to the Securities and ExchangeCommission or its staff upon request.

 

1

----